Skip to main navigation

Main Nav

About Us
Scientific Platform
Our Pipeline
Career Opportunities
Investors & Media

Press Releases

IR Nav

Overview
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Investor Contact

Shareholder Tools

Press Releases

Year

Gritstone to Participate in Upcoming Investor Conferences

November 17, 2022

Gritstone Announces Updated Overall Survival Results from GRANITE Phase 1/2 Study and Poster at SITC 2022

November 10, 2022

Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update

November 3, 2022

Gritstone bio Announces Private Placement of $45.0 Million

October 25, 2022

Gritstone Presents Positive Results from Two Phase 1 CORAL Studies, Providing Further Proof-of-Concept for Self-amplifying mRNA (samRNA) in Infectious Diseases

October 25, 2022

Gritstone to Host Data Update on CORAL and Discuss the Application of Self-amplifying mRNA (samRNA) in Infectious Diseases

October 19, 2022

Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 17, 2022

Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 20, 2022

Gritstone Presents Positive Initial Phase 2 Data in Late-Line Solid Tumor Patients Treated With KRAS-Directed Immunotherapy (SLATE) at ESMO 2022

September 12, 2022

Gritstone to Participate in Two Upcoming Investor Conferences

September 1, 2022

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

© 2024 Gritstone Bio |

Footer Links

Privacy Policy
Terms of Use
Cookie Policy
Contact

socials

Top